BeaverBeads™ Human B Cell Isolation Kit
Art.No. Specification List Price Qty Action
71005-50 for 5*10^8 cells Inquiry
71005-100 for 1*10^9 cells Inquiry

BeaverBeads® Human B Cell Isolation Kit(negative selection)


Product Introduction

This product isolates human B cells from human peripheral blood mononuclear cells (PBMCs) via negativeselection methodology. Biotinconjugated monoclonal antibodies are used to label nontarget cells (nonB cells), which are subsequently depleted by streptavidincoated magnetic beads to purify human B cells. No separation column is required; the kit works with a magnetic cell separator.


Product Features

  • High Purity: Delivers highly purified target cells, with human Bcell purity reaching up to 95.50%.

  • High Viability: Functional human B cells with no antibody markers can be obtained.

  • Rapid & Simple Workflow: No separation column required. Isolation can be completed within 25 minutes using a magnetic separator.


Performance Data

1. Cell Purity Analysis

Human B cells were isolated from PBMCs with the BeaverBeads® Human B Cell Isolation Kit. Cells pre and postisolation were stained with PE antihuman CD3 antibody (Clone: OKT3) and APC antihuman CD19 antibody (Clone: HIB19), followed by flow cytometric analysis. As shown in Figure 1, the purity of CD3⁻CD19⁺ cells was 18.39% before isolation and reached 95.50% after isolation.

Figure 1. Flow cytometric analysis of Bcell purity pre and postisolation


2. Cell Viability Analysis

Human B cells were isolated from PBMCs using the BeaverBeads® Human B Cell Isolation Kit. Cells before and after isolation were stained with 7AAD and analysed by flow cytometry. As shown in Figure 2, the viability of starting cells was 96.45%, while postisolation cell viability was 99.04%.

Figure 2. Flow cytometric detection of Bcell viability


3. Cellular Functional Assay

Human B cells were isolated from PBMCs using the BeaverBeads® Human B Cell Isolation Kit. Purified B cells were stimulated with R848 (1 μg/mL) and IL2 (10 ng/mL) for 24 h, and surface activation marker expression was measured by flow cytometry. As shown in Figure 3, stimulation with R848 plus IL2 markedly upregulated surface expression of CD69, CD25, CD80 and CD86 on B cells.

Figure 3. Upregulation of surface activation markers on B cells upon R848 and IL2 stimulation


4. Proliferation Assay

Human B cells were isolated from PBMCs with the BeaverBeads® Human B Cell Isolation Kit. Sorted B cells were labelled with CFSE, seeded, and stimulated with R848 (1 μg/mL) and IL2 (10 ng/mL) for 6 days. As presented in Figure 4, Obvious proliferation occurred in B cells.

Figure 4. Distinct proliferation of B cells induced by R848 and IL2 stimulation